Welcome : Guest

Declining Cost and Expanding Applications to Drive Market Growth for Next Generation Sequencers

Published: March 2017


  • Code: MCP-6811
  • Pages: 295
  • Tables: 47
  • Companies: 93


The global Next Generation Sequencers market is projected to exceed US$4.2 billion by 2022, driven by the growing adoption in an expanded range of applications, reduced cost of genome sequencing, and advent of ultra-high throughput sequencers with improved capabilities. Strong growth is projected for the market in the coming years driven by emerging applications for NGS technologies in areas such as cancer research, biomarker discovery, agricultural and animal sciences, and drug discovery. Growing world population and increasing incidences of diseases, such as cancer, infectious diseases, pre- and post-natal disorders and inherited rare disorders, are expected to spur application of sequencing data for the diagnosis and prognosis of infectious diseases and oncology. The United States represents the largest market worldwide. Presence of advanced healthcare technology framework, increasing R&D investments in proteomic and genomic sequence determination for biomarkers research, and rapid reduction in sequencing cost per each base pair are instrumental in making the country the world’s largest market for next generation sequencing products. Asia-Pacific is poised to grow at the fastest CAGR of 15.1% over the analysis period due largely to the rapidly improving healthcare infrastructure, favorable government policies, and the increased willingness to use novel solutions and platforms. 

    Summary of Findings

  • Declining Cost of Sequencing to Fuel Adoption of NGS Systems
  • Application of NGS in Drug Discovery and Development Benefits Market Growth
  • Personalized Medicine: Growing Prominence of NGS in Providing Customized Treatments to Patients
  • NGS Technology Drives RNA Sequencing in Transcriptomics
  • Advancements in Next Generation Sequencing (NGS) Technology Fuel Adoption
  • Effective Use of NGS Tools in Public Healthcare Systems Spurs Market Expansion

    Timeline for Analysis

  • Market Estimates and Forecasts for 2015-2022
  • Historic Review 2009-2014

    Geographic Markets Analyzed

  • US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia, and Rest of Europe), Asia-Pacific (China, and Rest of Asia-Pacific), Latin America, and Rest of World

    Market Segmentation & Classification

  • End-Use Segments:
    • Pharmaceutical/Biotech, Industrial, and Government/Academia


  • Agilent Technologies Inc.
  • Becton, Dickinson and Company
  • Fluidigm Corporation
  • Genomatix GmbH
  • Illumina, Inc.
  • Oxford Gene Technology
  • Oxford Nanopore Technologies
  • Pacific Biosciences of California, Inc.


  • Review of Industry/Market Structure
  • Analysis of Trends & Drivers
  • Insights on Macro Market Scenarios
  • Market SWOT Analysis
  • Latent Demand Forecasts & Projections
  • Comprehensive Geographic Market Analysis
  • Presentation Ready Facts & Statistical Data Findings
  • Coverage of Major/Niche Players, Market Shares & Competition
  • Coverage of major Company/Technology/Product/Financial Stories
  • Extensive Product/Service/End-Use/Technology Coverage Where Applicable